Deltex Medical (GB:DEMG) has released an update.
Deltex Medical Group PLC successfully held its annual general meeting with all resolutions passed, signaling steady progress for the company. The firm continues to innovate in haemodynamic monitoring technology, with a focus on expanding applications for both sedated and non-sedated patients across various healthcare settings. Their business model emphasizes recurring revenue through single-use disposable probes and a new non-invasive technology projected to broaden their market.
For further insights into GB:DEMG stock, check out TipRanks’ Stock Analysis page.
